Pricing Log in Create free account

Immuneering Corporation (IMRX) vs Korro Bio, Inc. (KRRO)

Immuneering Corporation and Korro Bio, Inc. are both Biotechnology companies. Immuneering Corporation is the larger, with a market value of $238.3M against $202.5M — 1.2× the size. Korro Bio, Inc. grew revenue faster over the last twelve months: −81.9% against −84.8%. Across the 13 metrics below, Immuneering Corporation leads on 7 and Korro Bio, Inc. on 6.

Valuation

Metric IMRX KRRO Biotechnology median
P/E n/m n/m 10.60
P/S 751.21 40.65 9.40
P/B 1.41 2.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 292.52 25.53 9.02
Earnings yield (28.10%) (67.80%) (32.88%)
Free cash flow yield (25.95%) (26.27%) (23.13%)

Profitability

Metric IMRX KRRO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.53%) (97.69%) (51.96%)
Return on assets (31.40%) (62.03%) (46.06%)
Return on invested capital (198.38%) 0.00% 0.00%

Growth

Metric IMRX KRRO Biotechnology median
Revenue growth (TTM) (84.76%) (81.87%) 6.76%
EPS growth (last fiscal year) 37.75% (33.19%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRX KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.97 9.55 4.97
Net debt to EBITDA 2.94 0.64 1.01

Dividend

Metric IMRX KRRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMRX KRRO Biotechnology median
Market cap 238.33m 202.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack